Masimo (MASI) Projected to Post Quarterly Earnings on Tuesday

Masimo (NASDAQ:MASI) is set to announce its quarterly earnings after the market closes on Tuesday, February 25th. Analysts are predicting that the company will report earnings of $1.42 per share and revenue of approximately $593.35 million for the quarter. Those interested in joining the company's conference call can use the provided link.

Masimo Stock Performance

On Tuesday, Masimo's stock opened at $181.31. The company has experienced significant fluctuations over the past year, reaching a low of $101.61 and a high of $183.14. Currently, the stock's 50-day moving average stands at $172.65, while the 200-day moving average is at $150.39. Financially, the company has a current ratio of 2.01, a quick ratio of 1.11, and a manageable debt-to-equity ratio of 0.50. With a market capitalization of $9.71 billion, Masimo has a price-to-earnings ratio of 125.04 and a beta of 1.02, indicating moderate volatility in stock price movements.

Analyst Insights on Masimo

Several research firms have commented on Masimo's stock recently. Piper Sandler raised their target price from $180.00 to $210.00, assigning the stock an “overweight” rating in December. Similarly, Wells Fargo & Company upped their price objective to $193.00, also giving Masimo an “overweight” rating. On the other hand, Needham & Company reiterated a “hold” rating. Stifel Nicolaus increased their price target to $190.00, while Raymond James set a new target of $194.00. Overall, there are two analysts with hold ratings and five with buy ratings on Masimo, resulting in a consensus rating of "Moderate Buy" with an average price target of $191.40.

About Masimo Corporation

Masimo Corporation engages in developing, manufacturing, and marketing various patient monitoring technologies and connectivity solutions around the globe. The company is known for its innovative medical devices including the Masimo Signal Extraction Technology (SET), which enhances pulse oximetry monitoring in challenging conditions like motion and low perfusion. Additionally, Masimo's rainbow SET platform provides noninvasive measurements for various blood metrics and offers advanced monitoring solutions such as SedLine brain function monitoring and regional oximetry.

Additional Resources

• Five stocks we like better than Masimo
• What is MarketRank™? How to Use it
• Airbnb's Earnings: Sky High Results, Grounded Guidance?
• How to Calculate Retirement Income: MarketBeat’s Calculator
• Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
• What is a support level?
• Conflicting Signals: Tempus AI's Stock Market Rally

Masimo, Earnings, Stocks